Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

FDMT4D Molecular Therapeutics, Inc.

Nasdaq · CIK 0001650648
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts255

Identity from submissions API

Name4D Molecular Therapeutics, Inc.
CIK0001650648
TickersFDMT
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN473506994
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone5105052680
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • 4D Molecular Therapeutics Inc. (2020-07-21T04:00:00.000Z → 2022-05-12T04:00:00.000Z)
  • 4D Molecular Therapeutics Inc (2015-08-13T04:00:00.000Z → 2019-09-30T04:00:00.000Z)
Business address
5858 HORTON STREET #455
EMERYVILLE
CA
94608
CA
Mailing address
5858 HORTON STREET #455
EMERYVILLE
CA
94608
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

444 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001388325-26-000053 005-91921 261561906 34 7684
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-003177 005-91921 261560981 34 25635
2026-11-12 10-Q 10-Q 0001193125-26-458477 001-39782 261547296 34 12976768 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458394 001-39782 261547051 34 364764 1 1
2026-11-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000602 005-91921 261537753 34 8198
2026-10-20 4 4 0001193125-26-426810 8904
2026-10-07 4 4 0001193125-26-417068 7530
2026-10-05 144 xsl144X01/primary_doc.xml 0001958244-26-000638 001-39782 261441851 33 11274
2026-09-28 8-K 8-K 8.01 0001193125-26-403424 001-39782 261412015 34 150904 1 1
2026-09-22 4 4 0001193125-26-398204 8828
2026-09-16 4 4 0001193125-26-393243 5580
2026-09-14 144 xsl144X01/primary_doc.xml 0001958244-26-000601 001-39782 261378566 33 11277
2026-09-03 4 4 0001193125-26-382245 8894
2026-08-21 4 4 0001193125-26-361096 11488
2026-08-19 144 xsl144X01/primary_doc.xml 0001958244-26-000539 001-39782 261296748 33 11189
2026-08-17 4 4 0001193125-26-354313 13604
2026-08-17 144 xsl144X01/primary_doc.xml 0001950047-26-008269 001-39782 261287301 33 7353
2026-08-13 144 xsl144X01/primary_doc.xml 0001950047-26-008088 001-39782 261274136 33 6410
2026-08-13 10-Q 10-Q 0001193125-26-349173 001-39782 261273370 34 13990250 1 1
2026-08-13 8-K 8-K 2.02 0001193125-26-349160 001-39782 261273259 34 421365 1 1
2026-08-05 4 4 0001193125-26-335115 5519
2026-08-04 144 xsl144X01/primary_doc.xml 0001958244-26-000477 001-39782 261240549 33 9639
2026-08-04 4 4 0001193125-26-333014 5583
2026-08-03 144 xsl144X01/primary_doc.xml 0001958244-26-000473 001-39782 261234648 33 8820
2026-07-20 8-K 8-K 8.01 0001193125-26-308409 001-39782 261185246 34 149974 1 1
2026-07-14 4 4 0001834021-26-000004 9482
2026-07-10 144 xsl144X01/primary_doc.xml 0001958244-26-000446 001-39782 261169258 33 8001
2026-07-09 144 xsl144X01/primary_doc.xml 0001958244-26-000444 001-39782 261166423 33 7182
2026-07-02 4 4 0001920738-26-000004 12648
2026-06-30 144 xsl144X01/primary_doc.xml 0001950047-26-006669 001-39782 261141080 33 6422
2026-06-29 8-K 8-K 1.01,2.03 0001193125-26-286880 001-39782 261131428 34 141173 1 1
2026-06-25 4 4 0001920738-26-000002 8879
2026-06-23 144 xsl144X01/primary_doc.xml 0001950047-26-006432 001-39782 261111420 33 4984
2026-06-23 4 4 0001834021-26-000002 5582
2026-06-22 144 xsl144X01/primary_doc.xml 0001958244-26-000396 001-39782 261108282 33 6364
2026-06-22 8-K 8-K 5.07 0001193125-26-277563 001-39782 261107403 34 186123 1 1
2026-06-18 4 4 0001193125-26-276168 6140
2026-06-18 4 4 0001193125-26-276166 6058
2026-06-18 4 4 0001193125-26-276163 6054
2026-06-18 4 4 0001193125-26-276160 6002
2026-06-18 4 4 0001193125-26-276149 5996
2026-06-18 4 4 0001193125-26-276144 5996
2026-06-18 4 4 0001193125-26-276138 6026
2026-06-02 4 4 0001193125-26-253740 5582
2026-06-01 144 xsl144X01/primary_doc.xml 0001958244-26-000339 001-39782 261052609 33 5541
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001346824-26-000143 005-91921 26988407 34 15585
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000921895-26-001391 005-91921 26987291 34 25558
2026-05-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001626 333-295650 26975632 33 1965
2026-05-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000093751-26-000197 005-91921 26966267 34 8226
2026-05-11 CORRESP filename1.htm 0001193125-26-216930 7391
2026-05-08 UPLOAD filename1.pdf 0000000000-26-004734 333-295650 148754
2026-05-07 S-3 S-3 0001193125-26-212323 333-295650 26954604 33 902208 1 1
2026-05-07 10-Q 10-Q 0001193125-26-211939 001-39782 26953455 34 10804105 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-211904 001-39782 26953334 34 276572 1 1
2026-04-28 ARS ARS 0001140361-26-017435 001-39782 26907672 34 1196840
2026-04-28 DEFA14A DEFA14A 0001140361-26-017430 001-39782 26907610 34 1048446
2026-04-28 DEF 14A DEF 14A 0001140361-26-017427 001-39782 26907591 34 5314496 1 1
2026-04-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000102 005-91921 26844603 34 12341
2026-03-30 8-K 8-K 5.02 0001193125-26-131739 001-39782 26813000 34 154196 1 1
2026-03-27 4 4 0001193125-26-129156 5903
2026-03-27 4 4 0001193125-26-129155 5871
2026-03-27 4 4 0001193125-26-129154 5944
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000363 005-91921 26794581 34 7388
2026-03-24 4 4 0001193125-26-122341 13952
2026-03-18 S-8 S-8 0001193125-26-114200 333-294420 26770103 33 224576 1 1
2026-03-18 10-K 10-K 0001193125-26-114075 001-39782 26769549 34 16758141 1 1
2026-03-18 8-K 8-K 2.02,9.01 0001193125-26-113949 001-39782 26769009 34 295631 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001388325-26-000011 005-91921 26644480 34 7606
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001346824-26-000029 005-91921 26641499 34 15482
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-26-000459 005-91921 26641328 34 25662
2026-02-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-26-000069 005-91921 26638881 34 12134
2026-02-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000886982-26-000038 005-91921 26611460 34 18424
2026-01-26 8-K 8-K 3.02,9.01 0001193125-26-022559 001-39782 26560526 34 357971 1 1
2026-01-07 4 4 0001193125-26-006809 5663
2026-01-07 3 3 0001193125-26-006805 28618
2026-01-07 8-K 8-K 2.02,5.02 0001193125-26-005470 001-39782 26514006 34 164337 1 1
2025-12-23 4 4 0001193125-25-331299 13816
2025-12-19 3 3 0001193125-25-326864 6307
2025-12-19 4 4 0001193125-25-326851 8686
2025-12-16 4 4 0001193125-25-320992 6735
2025-12-16 144 xsl144X01/primary_doc.xml 0001950047-25-010414 001-39782 251575931 33 8556
2025-12-11 4 4 0001193125-25-315989 5834
2025-12-11 3 3 0001193125-25-315962 27186
2025-12-10 8-K 8-K 8.01 0001193125-25-314167 001-39782 251562025 34 156348 1 1
2025-11-19 4 4 0001193125-25-288632 8762
2025-11-17 144 xsl144X01/primary_doc.xml 0001950047-25-008964 001-39782 251491469 33 7841
2025-11-17 8-K 8-K 5.02 0001193125-25-283861 001-39782 251489198 34 142392 1 1
2025-11-10 10-Q 10-Q 0001193125-25-273343 001-39782 251464513 34 12206215 1 1
2025-11-10 8-K 8-K 2.02,9.01 0001193125-25-273340 001-39782 251464499 34 335153 1 1
2025-11-07 8-K 8-K 8.01,9.01 0001193125-25-272286 001-39782 251462480 34 522478 1 1
2025-11-06 424B5 424B5 0001193125-25-269700 333-273845 251458831 33 807251
2025-11-06 8-K 8-K 2.02,8.01 0001193125-25-267934 001-39782 251455910 34 170737 1 1
2025-10-31 8-K 8-K 1.01 0001193125-25-259302 001-39782 251437798 34 142708 1 1
2025-10-27 4 4 0001193125-25-251874 8684
2025-10-24 144 xsl144X01/primary_doc.xml 0001950047-25-008163 001-39782 251416504 33 7711
2025-10-20 4 4 0001193125-25-243946 8762
2025-10-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001388325-25-000011 005-91921 251404627 34 7492
2025-10-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-002576 005-91921 251401820 34 11070
2025-10-14 4 4 0001193125-25-238995 4809
2025-10-10 3 3 0000950130-25-000195 9536
2025-10-02 8-K 8-K 5.02,5.03,9.01 0001193125-25-228289 001-39782 251368889 34 563568 1 1
2025-09-26 4 4 0001193125-25-221028 5041
2025-09-23 144 xsl144X01/primary_doc.xml 0001950047-25-007439 001-39782 251333864 33 5929
2025-08-11 10-Q 10-Q 0000950170-25-106244 001-39782 251200275 34 11314354 1 1
2025-08-11 8-K 8-K 2.02,9.01 0000950170-25-106243 001-39782 251200270 34 324040 1 1
2025-07-02 8-K 8-K 5.02,8.01 0000950170-25-092964 001-39782 251101122 34 160282 1 1
2025-06-20 4 4 0000950170-25-088497 5886
2025-06-20 4 4 0000950170-25-088496 5866
2025-06-20 4 4 0000950170-25-088489 6003
2025-06-20 4 4 0000950170-25-088487 5921
2025-06-20 4 4 0000950170-25-088486 5917
2025-06-20 4 4 0000950170-25-088484 5899
2025-06-20 8-K 8-K 5.07 0000950170-25-088482 001-39782 251061256 34 192033 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-013259 005-91921 25956164 34 24812
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-001547 005-91921 25954003 34 25530
2025-05-08 S-8 S-8 0001193125-25-116018 333-287089 25926860 33 199629 1 1
2025-05-08 10-Q 10-Q 0000950170-25-067040 001-39782 25926565 34 10684267 1 1
2025-05-08 8-K 8-K 2.02,9.01 0000950170-25-067013 001-39782 25926380 34 301927 1 1
2025-04-29 ARS ARS 0001140361-25-016323 001-39782 25887654 34 992473
2025-04-29 DEFA14A DEFA14A 0001140361-25-016320 001-39782 25887464 34 5215234
2025-04-29 DEF 14A DEF 14A 0001140361-25-016307 001-39782 25887148 34 5289846 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000599 005-91921 25844504 34 11065
2025-03-24 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000737 333-276872 25765596 33 1978
2025-03-10 4 4 0000950170-25-036696 5737
2025-03-10 4 4 0000950170-25-036688 5772
2025-03-10 4 4 0000950170-25-036686 5787
2025-03-10 4 4 0000950170-25-036685 5830
2025-03-10 4 4 0000950170-25-036683 5782
2025-02-28 POS AM POS AM 0001193125-25-042780 333-276872 25692005 33 552376
2025-02-28 S-8 S-8 0001193125-25-042758 333-285456 25691797 33 296146 1 1
2025-02-28 10-K 10-K 0000950170-25-030056 001-39782 25690770 34 15203983 1 1
2025-02-28 8-K 8-K 2.02,9.01 0000950170-25-030020 001-39782 25690418 34 309638 1 1
2025-02-28 POSASR POSASR 0001193125-25-042482 333-276872 25690196 33 802368 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004273 005-91921 25631685 34 20060
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004236 005-91921 25631568 34 24831
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-000489 005-91921 25629234 34 25566
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000045 005-91921 25625168 34 9757
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-000872 005-91921 25623514 34 11592
2025-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000769993-25-000070 005-91921 25606797 34 16843
2025-02-10 8-K 8-K 8.01 0000950170-25-016708 001-39782 25603819 34 175580 1 1
2025-01-10 8-K 8-K 2.02,8.01,9.01 0000950170-25-003832 001-39782 25520608 34 8214883 1 1
2024-12-11 8-K 8-K 3.02,9.01 0000950170-24-135381 001-39782 241541724 34 342875 1 1
2024-12-10 4 xslF345X05/form4-12102024_091224.xml 0001415889-24-028837 14031
2024-12-06 SC 13G/A us35104e1001_120624.txt 0002012383-24-004549 005-91921 241532642 34 14128
2024-11-25 3 xslF345X02/form3-11252024_091136.xml 0001415889-24-027636 13525
2024-11-15 SC 13G/A SC 13G/A 0001104659-24-119770 005-91921 241468796 34 92922
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119280 005-91921 241464735 34 91495
2024-11-14 SC 13G/A sayw24111424_13ga.htm 0000905148-24-003166 005-91921 241463189 34 255285
2024-11-14 SC 13G/A JANUS AMENDMENT 0001274173-24-000137 005-91921 241460842 34 10726
2024-11-14 SC 13G/A deeptrack-fdmt093024a4.htm 0001172661-24-004728 005-91921 241457671 34 103263
2024-11-13 4 OWNERSHIP DOCUMENT 0000921895-24-002631 35598
2024-11-13 10-Q 10-Q 0000950170-24-126370 001-39782 241454763 34 11154812 1 1
2024-11-13 8-K 8-K 2.02,9.01 0000950170-24-126346 001-39782 241454530 34 318744 1 1
2024-11-13 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0000921895-24-002625 005-91921 241454187 34 277104
2024-11-12 SC 13G/A UnitedStates_13G__4DMolecula.txt 0000932471-24-000815 005-91921 241445936 34 6776
2024-11-08 SC 13G/A us35104e1001_110824.txt 0002012383-24-003680 005-91921 241439820 34 14126
2024-11-06 SC 13G 4DMolecular.txt 0000769993-24-000356 005-91921 241432485 34 24008
2024-11-04 SC 13G UnitedStates_13G__4DMolecula.txt 0000932471-24-000236 005-91921 241421346 34 5809
2024-10-21 SC 13G/A us35104e1001_102124.txt 0002012383-24-000961 005-91921 241383587 34 14114
2024-09-18 4 4 0000950170-24-107903 8772
2024-09-18 8-K 8-K 8.01 0001193125-24-221375 001-39782 241307508 34 162855 1 1
2024-08-21 4 4 0000950170-24-099505 8772
2024-08-08 10-Q 10-Q 0000950170-24-094010 001-39782 241188590 34 10553626 1 1
2024-08-08 8-K 8-K 2.02,9.01 0000950170-24-093992 001-39782 241188528 34 324612 1 1
2024-08-01 3 OWNERSHIP DOCUMENT 0000921895-24-001663 24220
2024-07-23 8-K 8-K 7.01 0001193125-24-182544 001-39782 241132836 34 149382 1 1
2024-07-18 4 4 0000950170-24-084725 12680
2024-07-17 8-K 8-K 8.01 0001193125-24-179950 001-39782 241120898 34 172570 1 1
2024-07-15 4 4 0000950170-24-083712 9008
2024-07-12 4 4 0000950170-24-083303 13129
2024-07-10 144 xsl144X01/primary_doc.xml 0001958244-24-003356 001-39782 241110579 33 7229
2024-07-03 4 4 0000950170-24-081626 13227
2024-07-01 144 xsl144X01/primary_doc.xml 0001950047-24-005145 001-39782 241091298 33 7370
2024-06-26 4 4 0000950170-24-077944 9365
2024-06-25 144/A xsl144X01/primary_doc.xml 0001958244-24-002818 001-39782 241069499 33 5782
2024-06-24 144 xsl144X01/primary_doc.xml 0001958244-24-002817 001-39782 241065536 33 6320
2024-06-20 4 4 0000950170-24-075692 13224
2024-06-07 8-K 8-K 1.01,9.01 0001193125-24-157521 001-39782 241030575 34 426802 1 1
2024-06-07 424B5 424B5 0001193125-24-157513 333-276872 241030532 33 1178083
2024-05-24 8-K 8-K 5.07 0001193125-24-147093 001-39782 24984818 34 153740 1 1
2024-05-23 4 4 0000950170-24-064259 6010
2024-05-23 4 4 0000950170-24-064221 5902
2024-05-23 4 4 0000950170-24-064220 5933
2024-05-23 4 4 0000950170-24-064211 5930
2024-05-23 4 4 0000950170-24-064210 5912
2024-05-23 4 4 0000950170-24-064208 5878
2024-05-20 4 4 0000950170-24-062637 15171
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-057035 001-39782 24931072 34 291359 1 1
2024-05-09 10-Q 10-Q 0000950170-24-056933 001-39782 24930604 34 9675241 1 1
2024-04-18 4 4 0000950170-24-045702 12679
2024-04-10 ARS ARS 0001140361-24-019098 001-39782 24835821 34 1510845
2024-04-10 DEFA14A DEFA14A 0001140361-24-019094 001-39782 24835808 34 1281676
2024-04-10 DEF 14A DEF 14A 0001140361-24-019090 001-39782 24835782 34 2116777
2024-04-03 4 4 0000950170-24-041418 20497
2024-04-01 144 xsl144X01/primary_doc.xml 0001950047-24-002792 001-39782 24809802 33 8700
2024-03-29 4 4 0000950170-24-038731 12832
2024-03-20 4 4 0000950170-24-034227 12679
2024-02-29 4 4 0000950170-24-023330 8782
2024-02-29 S-8 S-8 0001193125-24-053647 333-277547 24705103 33 82182
2024-02-29 10-K 10-K 0000950170-24-023183 001-39782 24704477 34 13672280 1 1
2024-02-29 8-K 8-K 2.02,9.01 0000950170-24-023088 001-39782 24703751 34 289184 1 1
2024-02-21 4 4 0000950170-24-018155 12678
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024228 005-91921 24641702 34 147650
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023988 005-91921 24640169 34 107478
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036378 005-91921 24639409 34 38929
2024-02-14 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0000921895-24-000449 005-91921 24633363 34 277443
2024-02-14 SC 13G/A deeptrack-fdmt123123a3.htm 0001172661-24-000920 005-91921 24632646 34 103143
2024-02-13 SC 13G/A JHG PLC OWNS >5% 0001274173-24-000022 005-91921 24623451 34 10730
2024-02-12 4 4 0000950170-24-014119 19394
2024-02-12 4 4 0000950170-24-014091 5401
2024-02-09 8-K 8-K 8.01,9.01 0001193125-24-030203 001-39782 24615844 34 543914 1 1
2024-02-08 144 xsl144X01/primary_doc.xml 0001958244-24-000528 001-39782 24609849 33 10457
2024-02-08 424B5 424B5 0001193125-24-028376 333-276872 24609430 33 1570333
2024-02-08 144 xsl144X01/primary_doc.xml 0001950047-24-000765 001-39782 24609418 33 4989
2024-02-07 4 4 0000950170-24-012456 20799
2024-02-07 3/A 3/A 0000950170-24-012429 4324
2024-02-07 FWP FWP 0001193125-24-025587 333-276872 24601787 34 99681
2024-02-05 424B5 424B5 0001193125-24-024196 333-276872 24596946 33 1513846
2024-02-05 S-3ASR S-3ASR 0001193125-24-024104 333-276872 24596247 33 1383070
2024-01-25 SC 13G/A us35104e1001_012524.txt 0001086364-24-003759 005-91921 24562968 34 13774
2024-01-25 4 4 0000950170-24-007477 5403
2024-01-23 144 xsl144X01/primary_doc.xml 0001958244-24-000044 001-39782 24553202 33 9610
2024-01-08 4 4 0000950170-24-002945 13208
2024-01-08 SC 13G/A SC 13G/A 0001140361-24-001343 005-91921 24520293 34 256576
2024-01-08 SC 13G/A SC 13G/A 0001140361-24-001341 005-91921 24520065 34 265453
2024-01-05 4 xslF345X05/form4.xml 0000905148-24-000092 17887
2024-01-05 144 xsl144X01/primary_doc.xml 0001958244-24-000024 001-39782 24516905 33 7978
2024-01-04 144 xsl144X01/primary_doc.xml 0001958244-24-000019 001-39782 24513542 33 7158
2024-01-04 8-K 8-K 5.02 0001193125-24-001977 001-39782 24509831 34 145610 1 1
2023-12-18 144 xsl144X01/primary_doc.xml 0001958244-23-002836 001-39782 231494728 33 6347
2023-12-15 144 xsl144X01/primary_doc.xml 0001958244-23-002830 001-39782 231491442 33 5455
2023-12-13 4 4 0000950170-23-070016 5750
2023-12-13 4 4 0000950170-23-070015 5674
2023-12-13 4 4 0000950170-23-070013 5697
2023-12-13 4 4 0000950170-23-070014 5716
2023-12-13 4 4 0000950170-23-070012 5704
2023-11-22 8-K 8-K 5.03,9.01 0001193125-23-282259 001-39782 231433763 34 376560 1 1
2023-11-09 8-K 8-K 2.02,9.01 0000950170-23-062109 001-39782 231392915 34 403369 1 1
2023-11-09 10-Q 10-Q 0000950170-23-062103 001-39782 231392824 34 12913447 1 1
2023-10-03 4 xslF345X05/form4.xml 0001610717-23-000301 5568
2023-09-26 3 FORM 3 0001567619-23-007285 12345
2023-09-13 8-K 8-K 5.02 0001193125-23-233693 001-39782 231251459 34 151531 1 1
2023-08-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-08-15 16:00:00 9999999995-23-002401 333-273845 231176408 33 1924
2023-08-11 CORRESP filename1.htm 0001193125-23-210948 7412
2023-08-11 UPLOAD filename1.pdf 0000000000-23-008776 40441
2023-08-09 S-3 S-3 0001193125-23-207470 333-273845 231156148 33 740870
2023-08-09 10-Q 10-Q 0000950170-23-040661 001-39782 231155674 34 12418988 1 1
2023-08-09 8-K 8-K 2.02,9.01 0000950170-23-040653 001-39782 231155598 34 387479 1 1
2023-07-11 8-K 8-K 1.01 0001193125-23-184867 001-39782 231081092 34 149699 1 1
2023-06-12 4 xslF345X04/form4.xml 0001610717-23-000153 8573
2023-06-06 4 xslF345X04/form4.xml 0001610717-23-000098 9112
2023-06-05 SC 13G SC 13G 0001104659-23-068069 005-91921 23992983 34 75445
2023-05-25 4 xslF345X04/form4.xml 0001610717-23-000073 5670
2023-05-25 4 xslF345X04/form4.xml 0001610717-23-000072 5774
2023-05-25 4 xslF345X04/form4.xml 0001610717-23-000071 5688
2023-05-25 4 xslF345X04/form4.xml 0001610717-23-000070 5692
2023-05-25 4 xslF345X04/form4.xml 0001610717-23-000069 5637
2023-05-25 4 xslF345X04/form4.xml 0001610717-23-000068 5657
2023-05-25 4 xslF345X04/form4.xml 0001610717-23-000067 5689
2023-05-25 8-K 8-K 5.07 0001193125-23-154338 001-39782 23961753 34 152219 1 1
2023-05-16 4 xslF345X04/form4.xml 0001610717-23-000044 6730
2023-05-15 SC 13G SC 13G 0001104659-23-060800 005-91921 23922705 34 171068
2023-05-11 4 xslF345X04/form4.xml 0001140361-23-024202 17697
2023-05-11 10-Q 10-Q 0000950170-23-020703 001-39782 23908096 34 11211815 1 1
2023-05-11 8-K 8-K 2.02,9.01 0000950170-23-020699 001-39782 23908073 34 332590 1 1
2023-05-09 8-K 8-K 8.01,9.01 0001193125-23-139482 001-39782 23902872 34 432110 1 1
2023-05-08 424B5 424B5 0001193125-23-138372 333-263925 23898729 33 1506887
2023-05-04 4 xslF345X04/form4.xml 0001140361-23-023022 6250
2023-05-04 424B5 424B5 0001193125-23-135977 333-263925 23889309 33 1509229
2023-05-04 S-8 POS S-8 POS 0001193125-23-134747 333-270566 23886153 33 27335
2023-04-25 4 xslF345X04/form4.xml 0001140361-23-020316 8530
2023-04-25 4 xslF345X04/form4.xml 0001140361-23-020315 8626
2023-04-21 144 xsl144X01/primary_doc.xml 0001968582-23-000019 001-39782 23837325 33 4511
2023-04-21 144 xsl144X01/primary_doc.xml 0001950047-23-000207 001-39782 23836799 33 6211
2023-04-12 DEFA14A DEFA14A 0001193125-23-098528 001-39782 23814715 34 896912
2023-04-12 DEF 14A DEF 14A 0001193125-23-098511 001-39782 23814698 34 668853
2023-04-05 3 FORM 3 0001567619-23-005526 17724
2023-03-15 S-8 S-8 0001193125-23-071361 333-270566 23735590 33 80595
2023-03-15 8-K 8-K 2.02,9.01 0000950170-23-008146 001-39782 23735359 34 344230 1 1
2023-03-15 10-K 10-K 0000950170-23-008142 001-39782 23735334 34 19677610 1 1
2023-03-03 4 FORM 4 0001567619-23-004430 8873
2023-02-23 4 FORM 4 0001567619-23-003706 9443
2023-02-14 4 FORM 4 0001567619-23-003009 5766
2023-02-14 4 FORM 4 0001567619-23-003008 5836
2023-02-14 4 FORM 4 0001567619-23-003007 5845
2023-02-14 4 FORM 4 0001567619-23-003006 5844
2023-02-14 SC 13G/A deeptrack-fdmt123122a2.htm 0001172661-23-000826 005-91921 23622889 34 103060
2023-02-09 SC 13G/A JHI PLC OWNS <5% 0001274173-23-000003 005-91921 23601533 34 10254
2023-02-08 SC 13G/A SC 13G/A 0001193125-23-028417 005-91921 23599283 34 38696
2023-02-03 8-K 8-K 8.01 0001193125-23-023004 001-39782 23583028 34 154552 1 1
2023-01-31 SC 13G/A us35104e1001_013123.txt 0001306550-23-005186 005-91921 23571859 34 13466
2023-01-26 8-K 8-K 8.01 0001193125-23-016298 001-39782 23558410 34 188795 1 1
2023-01-23 4 FORM 4 0001567619-23-001163 7443
2022-12-22 4 FORM 4 0001567619-22-021958 7409
2022-12-19 4 FORM 4 0001567619-22-021815 11499
2022-12-05 4 FORM 4 0001567619-22-021291 27440
2022-11-09 8-K 8-K 2.02,9.01 0000950170-22-023839 001-39782 221372598 34 366904 1 1
2022-11-08 10-Q 10-Q 0000950170-22-023185 001-39782 221368767 34 13395603 1 1
2022-09-27 4 FORM 4 0001567619-22-017850 5856
2022-09-27 4 FORM 4 0001567619-22-017847 5846
2022-09-27 3 FORM 3 0001567619-22-017845 11334
2022-09-27 8-K 8-K 5.02 0001193125-22-252180 001-39782 221271407 34 149696 1 1
2022-09-06 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-09-06 16:00:00 9999999995-22-002599 333-267013 221229822 33 1924
2022-09-06 4 FORM 4 0001567619-22-017102 5798
2022-09-06 4 FORM 4 0001567619-22-017101 6338
2022-09-06 4 FORM 4 0001567619-22-017099 5909
2022-09-06 4 FORM 4 0001567619-22-017098 5843
2022-09-01 CORRESP filename1.htm 0001193125-22-236564 7035
2022-08-30 UPLOAD filename1.pdf 0000000000-22-009407 40405
2022-08-23 S-3 S-3 0001193125-22-226652 333-267013 221184840 33 313394
2022-08-11 8-K 8-K 2.02,9.01 0000950170-22-016890 001-39782 221156156 34 360004 1 1
2022-08-11 10-Q 10-Q 0000950170-22-016882 001-39782 221156073 34 12348099 1 1
2022-06-27 3 OWNERSHIP DOCUMENT 0000921895-22-002106 23586
2022-06-21 4 FORM 4 0001567619-22-013209 5839
2022-06-21 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0000921895-22-002049 005-91921 221028786 34 277239
2022-06-21 8-K 8-K 5.03,9.01 0001193125-22-176718 001-39782 221025617 34 366000 1 1
2022-05-27 8-K 8-K 5.07 0001193125-22-162490 001-39782 22979057 34 150909 1 1
2022-05-25 4 FORM 4 0001567619-22-011723 6105
2022-05-25 4 FORM 4 0001567619-22-011722 6026
2022-05-25 4 FORM 4 0001567619-22-011721 6007
2022-05-25 4 FORM 4 0001567619-22-011720 6025
2022-05-25 4 FORM 4 0001567619-22-011719 5973
2022-05-25 4 FORM 4 0001567619-22-011718 5998
2022-05-12 8-K 8-K 2.02,9.01 0000950170-22-009715 001-39782 22918404 34 315640 1 1
2022-05-12 10-Q 10-Q 0000950170-22-009702 001-39782 22918295 34 11123789 1 1
2022-04-15 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2022-04-15 16:00:00 9999999995-22-000994 333-263925 22830951 33 1814
2022-04-13 CORRESP filename1.htm 0001193125-22-104373 7677
2022-04-13 DEFA14A DEFA14A 0001193125-22-104271 001-39782 22824791 34 1058961
2022-04-13 DEF 14A DEF 14A 0001193125-22-104263 001-39782 22824765 34 708458
2022-04-04 UPLOAD filename1.pdf 0000000000-22-003630 40313
2022-03-31 3 FORM 3 0001567619-22-007790 13905
2022-03-29 S-3 S-3 0001193125-22-087325 333-263925 22777309 33 3397500
2022-03-28 S-8 S-8 0001193125-22-086836 333-263908 22776345 33 77385
2022-03-28 10-K 10-K 0000950170-22-004794 001-39782 22776022 34 16085692 1 1
2022-03-28 8-K 8-K 2.02,9.01 0000950170-22-004792 001-39782 22775910 34 323813 1 1
2022-02-22 8-K 8-K 5.02 0001193125-22-048643 001-39782 22658896 34 143118 1 1
2022-02-14 SC 13G/A SC 13G/A 0001140361-22-005382 005-91921 22634304 34 244708
2022-02-14 SC 13G/A SC 13G/A 0001193125-22-041906 005-91921 22633068 34 36012
2022-02-14 SC 13G/A SC 13G/A 0001193125-22-041901 005-91921 22633021 34 37115
2022-02-14 SC 13G/A deeptrack-fdmt123121a1.htm 0001172661-22-000418 005-91921 22625819 34 102952
2022-02-11 SC 13G/A SC 13G/A 4D MOLECULAR 0000078003-22-000006 005-91921 22620438 34 62703
2022-02-11 SC 13G JANUS HENDERSON GROUP PLC OWNS >5% 0001274173-22-000078 005-91921 22620083 34 10642
2022-02-09 SC 13G/A filing.txt 0000315066-22-000757 005-91921 22604141 34 8618
2022-02-04 SC 13G us35104e1001_020422.txt 0000834237-22-007098 005-91921 22593381 34 13417
2022-02-03 4 FORM 4 0001567619-22-002468 6080
2022-02-03 4 FORM 4 0001567619-22-002467 5602
2022-02-03 4 FORM 4 0001567619-22-002466 6204
2022-02-03 4 FORM 4 0001567619-22-002465 5651
2022-02-03 4 FORM 4 0001567619-22-002464 5540
2022-01-11 8-K 8-K 7.01,9.01 0001193125-22-006255 001-39782 22522724 34 12128546 1 1
2021-11-10 8-K 8-K 2.02,9.01 0000950170-21-004099 001-39782 211396974 34 359517 1 1
2021-11-10 10-Q 10-Q 0000950170-21-004086 001-39782 211396828 34 11166562 1 1
2021-11-04 SC 13G deeptrack-fdmt102921.htm 0001172661-21-002113 005-91921 211380987 34 102931
2021-11-01 424B4 424B4 0001193125-21-315511 333-260508 211367770 33 670097
2021-10-28 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2021-10-28 16:00:00 9999999995-21-004087 333-260508 211360466 33 1815
2021-10-26 CORRESP filename1.htm 0001193125-21-308197 8910
2021-10-26 CORRESP filename1.htm 0001193125-21-308193 7145
2021-10-26 S-1 S-1 0001193125-21-308105 333-260508 211349546 33 988978
2021-10-26 8-K 8-K 8.01 0001193125-21-307156 001-39782 211345868 34 169413 1 1
2021-10-22 4 FORM 4 0001567619-21-018628 9261
2021-10-13 8-K 8-K 8.01 0001193125-21-297865 001-39782 211321638 34 163273 1 1
2021-10-13 UPLOAD filename1.pdf 0000000000-21-012372 40595
2021-10-08 DRS filename1.htm 0000950123-21-012961 377-05573 211313705 33 793713
2021-10-01 4 FORM 4 0001567619-21-017751 13263
2021-09-29 4 FORM 4 0001567619-21-017624 12526
2021-09-24 8-K 8-K 5.02,9.01 0001193125-21-282451 001-39782 211278023 34 362681 1 1
2021-08-12 10-Q 10-Q 0001564590-21-043998 001-39782 211167877 34 9688174 1 1
2021-08-12 8-K 8-K 2.02,9.01 0001564590-21-043986 001-39782 211167781 34 352263 1 1
2021-07-06 SC 13G THE SCHEDULE 13G 0000921895-21-001775 005-91921 211074932 34 285313
2021-06-25 8-K 8-K 1.02,8.01,9.01 0001564590-21-034575 001-39782 211047639 34 248190 1 1
2021-06-09 4 FORM 4 0001567619-21-011946 5715
2021-06-09 3 FORM 3 0001567619-21-011945 11070
2021-05-20 8-K 8-K 5.07 0001564590-21-029069 001-39782 21944519 34 187108 1 1
2021-05-19 4 FORM 4 0001567619-21-010751 5918
2021-05-19 4 FORM 4 0001567619-21-010750 5848
2021-05-19 4 FORM 4 0001567619-21-010749 5890
2021-05-19 4 FORM 4 0001567619-21-010748 7964
2021-05-19 4 FORM 4 0001567619-21-010747 5917
2021-05-19 4 FORM 4 0001567619-21-010746 5997
2021-05-19 4 FORM 4 0001567619-21-010745 5865
2021-05-13 10-Q 10-Q 0001564590-21-027576 001-39782 21919966 34 8514260 1 1
2021-05-13 8-K 8-K 2.02,9.01 0001564590-21-027559 001-39782 21919823 34 300704 1 1
2021-04-14 4 FORM 4 0001567619-21-008045 6815
2021-04-06 DEFA14A DEFA14A 0001193125-21-107770 001-39782 21810025 34 207328
2021-04-06 DEF 14A DEF 14A 0001193125-21-107762 001-39782 21809993 34 637180
2021-03-25 S-8 S-8 0001193125-21-094535 333-254701 21772945 33 72884
2021-03-25 10-K 10-K 0001564590-21-015502 001-39782 21772616 34 25134814 1 1
2021-03-25 8-K 8-K 2.02,9.01 0001193125-21-094446 001-39782 21772483 34 71846
2021-03-10 4 FORM 4 0001567619-21-005968 5648
2021-03-10 4 FORM 4 0001567619-21-005967 5614
2021-03-10 4 FORM 4 0001567619-21-005966 5541
2021-02-16 SC 13G/A SCHEDULE 13G/A 0001104659-21-024046 005-91921 21638778 34 91984
2021-02-16 SC 13G SC 13G 0001193125-21-042200 005-91921 21631575 34 38243
2021-02-16 SC 13G SC 13G 0001193125-21-042194 005-91921 21631566 34 38183
2021-02-16 SC 13G/A AMENDMENT NO. 1 0001387131-21-002340 005-91921 21631277 34 129068
2021-02-16 SC 13G 4D MOLECULAR SC 13G 0000078003-21-000035 005-91921 21630835 34 67382
2021-02-08 SC 13G filing.txt 0000315066-21-000816 005-91921 21599325 34 8544
2020-12-23 SC 13G SCHEDULE 13G 0001104659-20-139059 005-91921 201412223 34 81664
2020-12-21 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-20-011460 005-91921 201405202 34 151868
2020-12-17 4 OWNERSHIP DOCUMENT 0001387131-20-011272 26498

Latest XBRL company facts

One latest value per concept from companyfacts (255 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 49.78M 2024-02-23 2023 FY 10-K 2024-02-29 0000950170-24-023183
dei EntityPublicFloat Entity Public Float USD 166.46M 2025-06-30 2025 FY 10-K 2026-03-18 0001193125-26-114075
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.43M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017427
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.72M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017427
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 3.29M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017427
ecd PeoTotalCompAmt PeoTotalCompAmt USD 2.05M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017427
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 33.77 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017427
ffd NetFeeAmt NetFeeAmt USD 27,620 2026-05-05 S-3 2026-05-07 0001193125-26-212323
ffd TtlFeeAmt TtlFeeAmt USD 27,620 2026-05-05 S-3 2026-05-07 0001193125-26-212323
ffd TtlOfferingAmt TtlOfferingAmt USD 400.00M 2026-05-05 S-3 2026-05-07 0001193125-26-212323
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-05 S-3 2026-05-07 0001193125-26-212323
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-05 S-3 2026-05-07 0001193125-26-212323
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 7.88M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 0 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2022-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008142
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 3.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 35.21M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 6.98M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 24.34M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.27B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 8.26M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 1.15M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008142
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 18.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 13.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap Assets Assets USD 428.75M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap AssetsCurrent Assets, Current USD 322.29M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 70.69M 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004086
us-gaap AvailableForSaleSecuritiesNoncurrent Available-for-sale Securities, Noncurrent USD 65.49M 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004086
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 67,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 39.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 514.00M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 39.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -21.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 18 2020-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 45,000 2016-12-31 2022 Q3 10-Q 2022-11-08 0000950170-22-023185
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2021-06-30 2021 Q2 10-Q 2021-08-12 0001564590-21-043998
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 32.33M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 56.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 56.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap CommonStockValue Common Stock, Value, Issued USD 6,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -221.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 1.31M 2024-09-30 2024 Q3 10-Q 2024-11-13 0000950170-24-126370
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 360,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 2.83M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 0 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-067040
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 293.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap DebtSecuritiesAvailableForSaleRealizedGain Debt Securities, Available-for-sale, Realized Gain USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008142
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008142
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 5.14M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap DeferredRentCredit Deferred Rent Credit USD 1.00M 2021-01-01 2022 FY 10-K 2023-03-15 0000950170-23-008142
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 1.24M 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 232,000 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 618,000 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 163.70M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015502
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 74.37M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 11.37M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 6.78M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 3.49M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 158.56M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 1.33M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap Depreciation Depreciation USD 3.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 3.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 400,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 397,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap DividendsCommonStock Dividends, Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 561,000 2021-03-31 2021 Q1 10-Q 2021-05-13 0001564590-21-027576
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015502
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 0 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015502
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.13 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.82 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009702
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.13 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.212 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.018 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.076 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.024 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0000950170-24-023183
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.024 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 11.71M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 54.50M 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-030056
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009702
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009702
us-gaap FairValueLiabilitiesLevel1ToLevel2TransfersAmount Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009702
us-gaap FairValueLiabilitiesLevel2ToLevel1TransfersAmount Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount USD 0 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009702
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008142
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008142
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008142
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008142
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -51,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 39.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 29.66M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 29.42M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 196,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 2.51M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -3.31M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -3.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-29 0000950170-24-023183
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 13.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 2.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 39,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -2.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 2.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 4.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 13.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 1.15M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001564590-21-043998
us-gaap LeaseCost Lease, Cost USD 6.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.077 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009702
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 23.31M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 5.46M 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-030056
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 5.35M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 5.46M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 5.46M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 5.67M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 5.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 4.58M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap Liabilities Liabilities USD 90.81M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 428.75M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap LiabilitiesCurrent Liabilities, Current USD 52.39M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 19.68M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap MarketableSecurities Marketable Securities USD 335.93M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 267.88M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 68.04M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 54.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 119.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -194.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -219.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -219.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 12.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OperatingExpenses Operating Expenses USD 242.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -231.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OperatingLeaseCost Operating Lease, Cost USD 3.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 2.60M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 18.73M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 5.31M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 13.42M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OperatingLeasePayments Operating Lease, Payments USD 4.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 15.76M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 2.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.109 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 298.30M 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-030056
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 126,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 11.44M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -1.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 2.08M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -951,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap OtherSundryLiabilitiesNoncurrent Other Sundry Liabilities, Noncurrent USD 120,000 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale, Recognized in Earnings USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008142
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 92,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap PaymentsForTenantImprovements Payments for Tenant Improvements USD 2.30M 2021-02-01 2021-02-28 2021 Q3 10-Q 2021-11-10 0000950170-21-004086
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-056933
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 180.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 104,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 11.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 205.66M 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015502
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008142
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 19.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 25.00M 2016-01-01 2016-12-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009702
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 471,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0000950170-22-023185
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 299.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 3.11M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-056933
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 658,000 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-09 0000950170-23-040661
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -219.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 35.56M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 11.22M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap PurchaseObligation Purchase Obligation USD 4.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 43.83M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-10 0000950170-21-004086
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 203.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015502
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 3.20M 2025-09-30 2025 Q3 10-Q 2025-11-10 0001193125-25-273343
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.25 2025-07-02 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap RestructuringCharges Restructuring Charges USD 3.00M 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-10 0001193125-25-273343
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 918,000 2025-06-30 2025 Q2 10-Q 2025-08-11 0000950170-25-106244
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -936.06M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 10.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 249,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap Revenues Revenues USD 10.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 23 2020-12-11 2020 FY 10-K 2021-03-25 0001564590-21-015502
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 18.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.89 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.859 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.041 2025-04-01 2025-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349173
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.046 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.038 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 1.63M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062103
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 3.18M 2023-09-30 2023 Q3 10-Q 2023-11-09 0000950170-23-062103
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 999,000 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 6.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 16.9 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 700,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 422,605 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 346,692 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 4.56M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 11.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 14.53 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 4.56M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 11.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 14.53 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 24.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0000950170-25-030056
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 6.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 16.77 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 12.19 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 5.84 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 337.94M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap StockIssued1 Stock Issued USD 545,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 330,688 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 175.45M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1.13M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 115.09M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-15 0000950170-23-008142
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.04M 2023-07-01 2023-09-30 2024 Q3 10-Q 2024-11-13 0000950170-24-126370
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 102.98M 2019-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 108.60M 2019-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015502
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 7.38M 2019-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 7.38M 2019-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2021-01-01 2024 FY 10-K 2025-02-28 0000950170-25-030056
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD 72.47M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 11.44M 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 4.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-28 0000950170-25-030056
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 30.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-18 0001193125-26-114075
us-gaap VariableLeaseCost Variable Lease, Cost USD 2.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 70.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 32.23M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009702
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-25 0001564590-21-015502
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 27.73M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-28 0000950170-22-004794
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 70.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458477

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →